Who is Jyoti K. Mehra and what is her background?

Jyoti K. Mehra is a newly appointed director to Lam Research's Board. She has extensive experience in Human Resources, most recently serving as Executive Vice President of Human Resources at Gilead Sciences, Inc. Prior to that, she held various senior HR leadership roles at Novartis Pharmaceuticals Corporation.

What is the significance of Jyoti K. Mehra's appointment for Lam Research?

Ms. Mehra's appointment is significant as it adds a director with deep expertise in Human Resources, a crucial function for managing talent, organizational development, and corporate culture within a global technology company. This strengthens the board's oversight in these areas.

How does this appointment affect the size of the Board of Directors?

With the appointment of Ms. Mehra, the size of Lam Research's Board of Directors has increased to 10 members.

What kind of compensation will Ms. Mehra receive?

Ms. Mehra will receive compensation for her services as a director that is consistent with Lam Research's current policies for compensating non-employee directors. She will also be covered by the company's standard form of indemnification agreement.

LRCX 8-K: Leadership Changes

Summary

Lam Research Corporation (LRCX) announced a significant addition to its Board of Directors with the appointment of Jyoti K. Mehra, effective November 9, 2021. Ms. Mehra brings extensive experience in Human Resources, having served in executive roles at Gilead Sciences, Inc. and Novartis Pharmaceuticals Corporation. Her appointment is expected to strengthen the board's expertise in human capital management, a critical area for a global technology company like Lam Research. This appointment increases the size of the board to 10 members. Ms. Mehra will receive standard compensation for non-employee directors and will be subject to the company's standard indemnification agreement. Investors should note that this 8-K filing primarily concerns a board-level appointment and does not include financial performance updates or material changes in company operations.

Key Highlights

1Appointment of Jyoti K. Mehra as a new director to the Board, effective November 9, 2021.
2Jyoti K. Mehra has a strong background in Human Resources, with recent executive roles at Gilead Sciences, Inc.
3Previous experience includes significant HR leadership positions at Novartis Pharmaceuticals Corporation.
4Ms. Mehra's appointment expands the Lam Research Board of Directors to 10 members.
5Compensation for Ms. Mehra as a director will follow the company's standard policies for non-employee directors.
6Lam Research will enter into its standard indemnification agreement with Ms. Mehra.

LAM RESEARCH CORP 8-K Report, Executive Changes (Nov 16, 2021)

Summary

Key Highlights

Frequently Asked Questions